EPS for East West Bancorp, Inc. (EWBC) Expected At $1.00; Premier Asset Managment Trimmed Gilead Sciences (GILD) Holding By $315,900

March 20, 2018 - By reb123z

Premier Asset Managment Llc decreased Gilead Sciences Inc (GILD) stake by 34.06% reported in 2017Q3 SEC filing. Premier Asset Managment Llc sold 3,900 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Premier Asset Managment Llc holds 7,550 shares with $612,000 value, down from 11,450 last quarter. Gilead Sciences Inc now has $101.10B valuation. The stock decreased 3.21% or $2.56 during the last trading session, reaching $77.18. About 8.92 million shares traded or 4.39% up from the average. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since March 20, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Analysts expect East West Bancorp, Inc. (NASDAQ:EWBC) to report $1.00 EPS on April, 18.They anticipate $0.12 EPS change or 13.64% from last quarter’s $0.88 EPS. EWBC’s profit would be $144.54 million giving it 16.28 P/E if the $1.00 EPS is correct. After having $0.87 EPS previously, East West Bancorp, Inc.’s analysts see 14.94% EPS growth. The stock decreased 0.84% or $0.55 during the last trading session, reaching $65.11. About 829,475 shares traded. East West Bancorp, Inc. (NASDAQ:EWBC) has risen 46.25% since March 20, 2017 and is uptrending. It has outperformed by 29.55% the S&P500.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Oppenheimer given on Tuesday, October 20. On Tuesday, January 16 the stock rating was upgraded by Wells Fargo to “Outperform”. The stock has “Buy” rating by Jefferies on Tuesday, October 25. Credit Suisse initiated it with “Outperform” rating and $125 target in Wednesday, January 20 report. Oppenheimer maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, February 3. Oppenheimer has “Outperform” rating and $120 target. The firm has “Outperform” rating by Oppenheimer given on Thursday, February 11. The stock has “Buy” rating by Maxim Group on Thursday, November 30. The firm has “Buy” rating by Argus Research given on Thursday, August 31. Cowen & Co maintained it with “Buy” rating and $90.0 target in Wednesday, October 18 report. Mizuho maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, September 28 with “Buy” rating.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on May, 1. They expect $1.59 earnings per share, down 27.73% or $0.61 from last year’s $2.2 per share. GILD’s profit will be $2.08B for 12.14 P/E if the $1.59 EPS becomes a reality. After $1.60 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -0.63% negative EPS growth.

Since October 2, 2017, it had 0 buys, and 14 sales for $42.20 million activity. Alton Gregg H sold 14,435 shares worth $1.18 million. Meyers James R sold 100,000 shares worth $8.02M. Cogan John Francis had sold 5,833 shares worth $472,065 on Monday, March 12. MARTIN JOHN C also sold $6.05 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares. WILSON GAYLE E had sold 60,000 shares worth $4.68 million on Friday, February 9. On Wednesday, February 21 the insider Washington Robin L sold $401,566.

Investors sentiment decreased to 0.8 in Q3 2017. Its down 0.23, from 1.03 in 2017Q2. It dived, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Utd Cap Advisers Ltd Limited Liability Company invested in 0.23% or 334,578 shares. Public Employees Retirement Sys Of Ohio reported 0.38% in Gilead Sciences, Inc. (NASDAQ:GILD). Fiera Corp invested in 30,913 shares or 0.01% of the stock. Stratos Wealth Prtnrs Limited reported 0.18% in Gilead Sciences, Inc. (NASDAQ:GILD). 149,775 are owned by Connor Clark And Lunn Inv Mngmt Ltd. Retail Bank Of New York Mellon has 30.10M shares for 0.67% of their portfolio. Pictet Asset holds 3.46 million shares or 0.79% of its portfolio. Kepos Ltd Partnership owns 39,494 shares for 0.54% of their portfolio. Capital Sarl invested in 41,850 shares. Private Advisor Gp Lc holds 0.17% or 86,061 shares in its portfolio. Gulf Intl National Bank & Trust (Uk) owns 412,202 shares. Zacks Inv Mngmt invested 1.14% in Gilead Sciences, Inc. (NASDAQ:GILD). Barry Invest Advsrs Ltd holds 7,650 shares. Argent Management Ltd Liability Corp has invested 0.61% in Gilead Sciences, Inc. (NASDAQ:GILD). Glovista Investments Ltd Llc has invested 0.12% in Gilead Sciences, Inc. (NASDAQ:GILD).

Investors sentiment increased to 1.22 in Q3 2017. Its up 0.04, from 1.18 in 2017Q2. It increased, as 31 investors sold East West Bancorp, Inc. shares while 116 reduced holdings. 47 funds opened positions while 127 raised stakes. 124.37 million shares or 0.88% more from 123.29 million shares in 2017Q2 were reported. Arrowstreet Cap Partnership accumulated 5,900 shares. Artemis Invest Mngmt Ltd Liability Partnership invested 0.17% of its portfolio in East West Bancorp, Inc. (NASDAQ:EWBC). Lord Abbett Commerce Ltd Liability Co accumulated 0.61% or 3.50 million shares. Schwab Charles Inv Incorporated reported 598,351 shares. 192,849 were accumulated by Barclays Public Limited Company. 86,470 were accumulated by Pacific Global Investment. Jpmorgan Chase And owns 4.40M shares for 0.06% of their portfolio. Tompkins Corporation owns 75 shares. Savings Bank Of America Corporation De, a North Carolina-based fund reported 1.52 million shares. Envestnet Asset Mngmt reported 0% in East West Bancorp, Inc. (NASDAQ:EWBC). Verition Fund Lc reported 11,684 shares. Bluecrest Management holds 0.04% or 17,041 shares. Tiaa Cref Invest Mgmt Limited accumulated 683,231 shares or 0.03% of the stock. Cambiar Ltd Limited Liability Company has invested 0.07% in East West Bancorp, Inc. (NASDAQ:EWBC). Robeco Institutional Asset Bv invested 0.01% in East West Bancorp, Inc. (NASDAQ:EWBC).

Since October 24, 2017, it had 0 insider buys, and 5 selling transactions for $1.53 million activity. Another trade for 2,000 shares valued at $137,000 was made by LIU JACK C on Monday, January 29. $133,378 worth of East West Bancorp, Inc. (NASDAQ:EWBC) was sold by Chan Iris S. LI HERMAN Y sold $610,000 worth of East West Bancorp, Inc. (NASDAQ:EWBC) on Tuesday, October 24. On Tuesday, December 19 the insider KRAUSE DOUGLAS PAUL sold $306,286. Oh Irene H sold $341,432 worth of stock.

Among 14 analysts covering East West Bancorp Inc. (NASDAQ:EWBC), 8 have Buy rating, 0 Sell and 6 Hold. Therefore 57% are positive. East West Bancorp Inc. had 49 analyst reports since August 26, 2015 according to SRatingsIntel. Sandler O’Neill maintained the stock with “Buy” rating in Thursday, January 25 report. The firm earned “Buy” rating on Wednesday, February 24 by Deutsche Bank. Wells Fargo maintained East West Bancorp, Inc. (NASDAQ:EWBC) on Tuesday, January 9 with “Buy” rating. Piper Jaffray maintained East West Bancorp, Inc. (NASDAQ:EWBC) rating on Thursday, July 20. Piper Jaffray has “Buy” rating and $6800 target. Wells Fargo upgraded East West Bancorp, Inc. (NASDAQ:EWBC) on Friday, October 23 to “Outperform” rating. The rating was upgraded by Macquarie Research on Friday, July 22 to “Outperform”. The stock has “Overweight” rating by Barclays Capital on Friday, October 20. The stock has “Hold” rating by BMO Capital Markets on Thursday, January 25. Morgan Stanley maintained East West Bancorp, Inc. (NASDAQ:EWBC) rating on Wednesday, January 31. Morgan Stanley has “Equal-Weight” rating and $70 target. As per Monday, October 23, the company rating was maintained by SunTrust.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: